CMS Finalizes 2027 Home Health Rule With 2.4% Payment Increase and Stricter Anti-Fraud Enrollment Standards
WASHINGTON—The Centers for Medicare & Medicaid Services (CMS) has officially issued its highly anticipated final rule governing home health payments for Calendar Year (CY) 2027, establishing a net aggregate payment increase of approximately 2.4% for home health agencies nationwide. Announced on November 4, the CY 2027 Home Health Prospective Payment System (HH PPS) final rule mirrors the projections initially put forth during the proposed rule stage back in July. While the positive financial update provides a degree of revenue predictability for agencies navigating inflationary pressures and workforce shortages, the comprehensive regulatory package also introduces a wave of stringent anti-fraud enrollment mandates, adjustments to case-mix weights, and procedural updates designed to recalibrate public healthcare expenditures.
The finalized framework outlines a multi-layered financial structure. Specifically, CMS has mandated a home health payment update of 2.1%, which translates to a $365 million funding increase, alongside an estimated 0.3% bump reflecting an updated fixed dollar loss (FDL) amount, accounting for an additional $50 million. When aggregated across the board, the finalized policies will pump an estimated $415 million more into the Medicare home health sector compared to 2026 figures. However, these incoming revenues are balanced against ongoing statutory adjustments, including the continuation of behavioral assumptions management and a finalized temporary adjustment of -3.0% applied to the 2027 home health base payment rate.
Chronology and Background of the HH PPS Framework
To understand the weight of the CY 2027 final rule, industry analysts look back at the legislative and regulatory evolution that has reshaped home-based care over the past decade. The foundation of the current payment methodology was laid by the Bipartisan Budget Act of 2018, which mandated the implementation of a 30-day unit of payment and the Patient-Driven Groupings Model (PDGM). Enacted fully in January 2020, the PDGM shifted Medicare’s reimbursement focus from the volume of therapy visits provided to the actual clinical characteristics and patient needs of the individual receiving care.
Over subsequent years, CMS has continuously monitored how home health agencies adapted their coding and operational practices under the PDGM. Statutory requirements compel the agency to conduct ongoing analyses comparing assumed behavioral changes—such as shifts in clinical grouping and comorbidity reporting—against actual empirical data. When utilization patterns result in aggregate expenditures that diverge significantly from what would have occurred under legacy systems, CMS is authorized to implement permanent and temporary payment adjustments.
The regulatory timeline for the 2027 rule began taking shape in mid-summer, when CMS published its initial proposed rule. Throughout the mandated public comment period, industry stakeholders, trade associations, and healthcare providers submitted extensive feedback concerning the adequacy of the proposed payment updates, the implications of behavioral adjustments, and the operational burdens of proposed compliance mandates. While CMS ultimately moved forward with its baseline 2.4% net increase as proposed in July, the final rule also incorporates technical refinements based on stakeholder input, including recalibrated PDGM case-mix weights, updated low utilization payment adjustment (LUPA) thresholds, and revised functional impairment levels.
Combating Fraud: New Enrollment and Re-Enrollment Requirements
Beyond the financial adjustments, a central pillar of the CY 2027 final rule is the implementation of significantly heightened regulatory requirements for home health agencies, hospices, and home medical equipment (HME) providers seeking to enroll or re-enroll in the Medicare program. CMS has framed these measures as a direct extension of its aggressive, multi-pronged campaign to protect the Medicare Trust Funds from illicit actors, waste, and systemic abuse.
In recent years, federal oversight agencies and investigative journalists have uncovered numerous instances of fraudulent entities exploiting vulnerabilities in provider enrollment frameworks, frequently billing Medicare for services never rendered or establishing phantom storefronts. To close these avenues, the new rule equips CMS and its administrative contractors with expanded screening tools, stricter verification protocols, and enhanced authority to deny or revoke billing privileges for providers who fail to meet rigorous compliance thresholds.
Industry compliance experts note that these stricter enrollment hurdles will require administrative diligence from legitimate operators. While established providers with pristine compliance records are expected to navigate re-enrollment without catastrophic disruption, smaller or newly emerging agencies may face extended review timelines and increased documentation burdens as state and federal screeners meticulously verify ownership structures, physical locations, and operational compliance.
Advancing Community-Based Palliative Care Pathways
Within the documentation accompanying the CY 2027 rule, CMS dedicated specific attention to the integration of palliative care within the existing Medicare home health benefit. Responding to a rising tide of demographic demand as the Baby Boomer generation ages, stakeholders have increasingly advocated for formalized pathways that allow chronically and seriously ill patients to receive supportive, comfort-focused care in their residential settings.
In its published fact sheet, CMS explicitly affirmed its policy stance, noting that it "is interested in encouraging beneficiary access to community-based palliative care under the Medicare home health benefit and believes the Medicare home health benefit can be an important step in the care continuum when a patient needs palliative care."
Although the final rule did not incorporate exhaustive operational models or immediate reimbursement restructuring specifically designated for palliative care in this iteration, CMS addressed the extensive commentary submitted on the topic. The agency acknowledged the vital role that home health agencies play in delivering supportive care services and confirmed its intention to issue concrete, actionable examples and operational instructions through forthcoming sub-regulatory guidance. Health policy analysts view this as a clear signal that CMS intends to progressively weave palliative care concepts deeper into home health policy, laying the groundwork for more comprehensive structural integration in future rulemaking cycles.
Durable Medical Equipment, Infusion Pumps, and Face-to-Face Clarifications
The CY 2027 final rule also introduces critical updates governing Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), most notably regarding external infusion pumps and associated home infusion drugs.
Effective April 1, 2027, the rule expands coverage under the DME benefit to include specific external infusion pumps and necessary home infusion medications, provided they meet established clinical appropriateness criteria. Among these criteria is the fundamental requirement that the administered drug must be delivered by, or administered under the direct supervision of, a qualified healthcare professional. This expansion aims to bridge gaps in home-based acute and chronic disease management, allowing patients with complex pharmacological needs to receive hospital-grade infusion therapies safely within the comfort of their homes.
Furthermore, the rule resolves a long-standing operational ambiguity surrounding replacement items under DMEPOS regulations. CMS finalized a clear policy clarification stating that providers are not required to conduct an additional, comprehensive beneficiary "face-to-face" examination solely to gather subjective and objective clinical information when ordering and furnishing a replacement item—defined for these purposes as an item classified under the exact same Healthcare Common Procedure Coding System (HCPCS) code.
Under the updated framework, if a claim for a replacement DMEPOS item undergoes a post-payment audit, the provider must present documentation originating
from the original, initial face-to-face encounter to substantiate that foundational medical necessity, billing, and coverage criteria were satisfied. This clarification upholds the core consumer protection intent of federal regulations (specifically 42 C.F.R. 410.38) requiring face-to-face evaluations when equipment is initially prescribed, while eliminating redundant administrative hurdles for patients requiring routine equipment replacement.
Industry Reactions and Economic Implications
Reactions from the broader home healthcare community to the release of the final rule have been characterized by a mixture of cautious relief and persistent economic anxiety. National industry associations, while acknowledging that the 2.4% net payment increase is a step in the right direction compared to deeper cuts feared in prior years, argue that the cumulative impact of statutory behavioral adjustments—such as the finalized -3.0% temporary adjustment to the base payment rate—continues to squeeze institutional operating margins.
Home health executives point out that labor costs, registered nurse compensation, travel expenses, and technological overhead have risen sharply over the past several years. Consequently, trade groups have consistently maintained that annual payment updates frequently fail to keep pace with real-world inflationary pressures. Providers caution that inadequate reimbursement adjustments risk restricting patient access to care, particularly in rural and underserved urban communities where home health agencies operate on razor-thin margins and already struggle to recruit and retain qualified clinical staff.
Conversely, fiscal watchdogs and federal policymakers emphasize the necessity of balancing provider payment adequacy with responsible stewardship of public trust funds. From the perspective of CMS, implementing behavioral adjustments and temporary payment cuts is a necessary statutory mechanism to ensure that Medicare expenditures accurately reflect actual changes in clinical coding and service utilization under modern prospective payment models.
Looking Ahead to 2027 and Beyond
As the healthcare sector prepares for the implementation of the CY 2027 HH PPS final rule, attention is already turning to the logistical realities of compliance. Home health agencies, hospice operators, and HME providers face a multi-month window leading up to the January 1, 2027, effective date (with specific DME provisions taking effect April 1, 2027) to update their internal billing software, review clinical documentation workflows, and prepare administrative staff for the heightened enrollment screening standards.
At the same time, policy experts will be monitoring how CMS tracks behavioral changes under the PDGM and whether future rulemaking cycles will introduce permanent adjustments or further refine the low utilization payment adjustment thresholds. Ultimately, the CY 2027 rule underscores the federal government’s dual imperative: expanding access to innovative home-based therapies like infusion care and palliative support while aggressively fortifying administrative guardrails to secure the financial integrity of the Medicare program for generations to come.
